Elizabeth Gibb, MD

Dr. Elizabeth Gibb cares for children with complicated medical conditions and their families, with a commitment to managing their care both over time and during severe episodes. She specializes in treating asthma, bronchopulmonary dysplasia, interstitial lung disease, cystic fibrosis, primary ciliary dyskinesia, sleep apnea and respiratory conditions related to neuromuscular disease, as well as in performing flexible bronchoscopy and pulmonary function tests. Her research focuses on Cystic Fibrosis treatments.

Dr. Gibb earned a master of philosophy degree in biochemistry at the University of Cambridge and her medical degree from Harvard Medical School. She completed a residency in pediatrics and a fellowship in pediatric pulmonary medicine at UCSF. She is a member of the American Academy of Pediatrics. She wrote, produced and directed a UCSF teaching video on pediatric asthma.
Education
2013 - Pediatric Pulmonary Fellowship, University of California, San Francisco
2010 - Pediatric Residency, University of California, San Francisco
MD, 2007 - , Harvard
M. Phil, 2003 - Biochemistry, University of Cambridge
B.S., 2002 - Molecular, Cellular and Developmental Biology, Yale
Websites

  1. Abdelghani A, Cuneo A, Gibb E, Perito ER. Identifying Gaps and Disparities in Screening for Cystic Fibrosis Associated Liver Disease: Insights From a CF Center Analysis. Pediatric pulmonology 2025. PMID: 40265529


  2. Vaziri S, McGarry ME, Cuneo AA, Willen SM, Iwanaga K, Neemuchwala F, Gibb ER, Chan M, Ly NP. A Joint Conversation: People With Cystic Fibrosis' Perception of Healthcare Teams' Knowledge, Comfort, and Barriers in Discussing Substance Use. Pediatric pulmonology 2025. PMID: 40019020


  3. McGarry ME, Sciortino S, Graham S, Bishop T, Gibb ER. Improved detection of cystic fibrosis by the California Newborn Screening Program for all races and ethnicities. Pediatric pulmonology 2024. PMID: 38940324


  4. Vaziri S, McGarry ME, Huang CY, Cuneo AA, Willen SM, Iwanaga K, Neemuchwala F, Gibb ER, Chan M, Ly NP. Time to be blunt: Substance use in cystic fibrosis. Pediatric pulmonology 2024. PMID: 38251844


  5. Stoffella S, Ly N, McGarry M, Neemuchwala F, Church G, Chan M, Cuneo A, Omori M, Gibb E. Cystic fibrosis transmembrane conductance regulator modulator administration to a F508del heterozygous infant with meconium pseudocyst and short bowel syndrome: A case report. Pediatric pulmonology 2023. PMID: 38088240


  6. McGarry ME, Gibb ER, Laguna TA, O'Sullivan BP, Sawicki GS, Zobell JT. How Many Billions Is Enough? Prioritizing Profits Over Patients With Cystic Fibrosis. Pediatric pulmonology 2023. PMID: 36722731


  7. Lim JT, Ly NP, Willen SM, Iwanaga K, Gibb ER, Chan M, Church GD, Neemuchwala F, McGarry ME. Food insecurity and mental health during the COVID-19 pandemic in cystic fibrosis households. 2022. PMID: 35112507


  8. McGarry ME, Gibb ER, Oates GR, Schechter MS. Left behind: The potential impact of CFTR modulators on racial and ethnic disparities in cystic fibrosis. 2021. PMID: 35277357


  9. Hendra K, Neemuchwala F, Chan M, Ly NP, Gibb ER. Patient and Provider Experience With Cystic Fibrosis Telemedicine Clinic. 2021. PMID: 34900879


  10. Park JK, Shrivastava A, Zhang C, Pollok BA, Finkbeiner WE, Gibb ER, Ly NP, Illek B. Functional Profiling of CFTR-Directed Therapeutics Using Pediatric Patient-Derived Nasal Epithelial Cell Models. Frontiers in pediatrics 2020. PMID: 33014932


  11. Gibb ER, Thyne SM, Kaplan DN, Ly NP. Asthma, FEF25-75, and Hospitalizations in Children. Pediatric allergy, immunology, and pulmonology 2013. PMID: 35923031


  12. Gibb E, Blount R, Lewis N, Nielson D, Church G, Jones K, Ly N. Management of plastic bronchitis with topical tissue-type plasminogen activator. Pediatrics 2012. PMID: 22802609